Advertisement

Radiotherapy prioritization in 143 national cancer control plans: Correlation with radiotherapy machine availability, geography and income level

Published:September 13, 2022DOI:https://doi.org/10.1016/j.radonc.2022.09.001

      Highlights

      • The inclusion rate of radiotherapy within 55% of NCCPs falls short of the 80% target set by GTFRCC.
      • Inclusion of radiotherapy specific planning in NCCPs varied according to income level and geography.
      • Prioritisation of radiotherapy in NCCPs is correlated with radiotherapy machine availability.
      • This study supports the importance of including radiotherapy in a country’s NCCP.

      Abstract

      Background

      In 2015, the Global Task Force on Radiotherapy for Cancer Control (GTFRCC) called for 80% of National Cancer Control Plans (NCCP) to include radiotherapy by 2020. As part of the ongoing ESTRO Global Impact of Radiotherapy in Oncology (GIRO) project, we assessed whether inclusion of radiotherapy in NCCPs correlates with radiotherapy machine availability, national income, and geographic region.

      Methods

      A previously validated checklist was used to determine whether radiotherapy was included in each country’s NCCP. We applied the CCORE optimal radiotherapy utilisation model to the GLOBOCAN 2020 data to estimate the demand for radiotherapy and compared this to the International Atomic Energy Agency (IAEA) Directory of Radiotherapy Centres (DIRAC) supply data, stratifying by income level and world region. World regions were defined according to the IAEA.

      Findings

      Complete data (including GLOBOCAN 2020, DIRAC and NCCP) was available for 143 countries. Over half (55%, n = 79) included a radiotherapy-specific checklist item within the plan. Countries which included radiotherapy services planning in their NCCP had a higher median number of machines (1.68 vs 0.75 machines/1000 patients needing radiotherapy, p < 0.001). There was significant regional and income-level heterogeneity in the inclusion of radiotherapy-related items in NCCPs. Low-income and Asia-Pacific countries were least likely to include radiation oncology services planning in their NCCP (p = 0.06 and p = 0.003, respectively). Few countries in the Asia-Pacific (18.6%) had a plan to develop or maintain radiation services, compared to 57% of countries in Europe.

      Interpretation

      Only 55% of current NCCPs included any information regarding radiotherapy, below the GTFRCC’s target of 80%. Prioritisation of radiotherapy in NCCPs was correlated with radiotherapy machine availability. There was regional and income-level heterogeneity regarding the inclusion of specific radiotherapy checklist items in the NCCPs. Ongoing efforts are needed to promote the inclusion of radiotherapy in future iterations of NCCPs in order to improve global access to radiation treatment.

      Funding

      No direct funding was used in this research.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sung H.
        • Ferlay J.
        • Siegel R.L.
        • Laversanne M.
        • Soerjomataram I.
        • Jemal A.
        • et al.
        Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA: A Cancer J Clinicians. 2021; 71: 209-249
        • Wild C.
        • Weiderpass E.
        • Stewart B.
        World cancer report: cancer research for cancer prevention.
        International Agency for Research on Cancer, Lyon2020
      1. WHO. National Cancer Control Programmes 2016 [February 25, 2019]. Available from: http://www.who.int/cancer/nccp/en/.

      2. Cancer Care: Assuring Quality to Improve Survival 2013 [February 18, 2020]. Available from: https://www.oecd-ilibrary.org/content/publication/9789264181052-en.

      3. Cancer prevention and control in the context of an integrated approach WHA 70.12. 70th World Health Assembly; 2017.

        • Gorgojo L.
        • Harris M.
        • Garcia-Lopez E.
        National Cancer Control programmes: analysis of primary data from questionnaires. Report from European Partnership for Action Against.
        Cancer. 2012;
        • Oar A.
        • Moraes F.Y.
        • Romero Y.
        • Ilbawi A.
        • Yap M.L.
        Core elements of national cancer control plans: a tool to support plan development and review.
        Lancet. 2019; 20: e645-e652
      4. WHO. WHO report on cancer: setting priorities, investing wisely and providing care for all. 2020.

        • Romero Y.
        • Trapani D.
        • Johnson S.
        • Tittenbrun Z.
        • Given L.
        • Hohman K.
        • et al.
        National cancer control plans: a global analysis.
        Lancet Oncol. 2018; 19: e546-e555
        • Yap M.L.
        • Zubizarreta E.
        • Bray F.
        • Ferlay J.
        • Barton M.
        Global access to radiotherapy services: have we made progress during the past decade?.
        J Glob Oncol. 2016; 2: 207-215
        • Atun R.
        • Jaffray D.A.
        • Barton M.B.
        • Bray F.
        • Baumann M.
        • Vikram B.
        • et al.
        Expanding global access to radiotherapy.
        Lancet. 2015; 16: 1153-1186
        • Aiello Bowles E.J.
        • Tuzzio L.
        • Wiese C.J.
        • Kirlin B.
        • Greene S.M.
        • Clauser S.B.
        • et al.
        Understanding high-quality cancer care: a summary of expert perspectives.
        Cancer. 2008; 112: 934-942
        • Delaney G.P.
        • Barton M.B.
        Evidence-based estimates of the demand for radiotherapy.
        Clin Oncol. 2015; 27: 70-76
      5. Directory of Radiotherapy Centers 2020 [February 18, 2020]. Available from: https://dirac.iaea.org.

      6. World Bank Country and Lending Groups 2020 [February 18, 2020]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519.

      7. IAEA. Roadmap towards a National Cancer Control Programme: Milestones for establishing nuclear medicine, diagnostic imaging and radiotherapy services. 2019.

        • Lievens Y.
        • Gospodarowicz M.
        • Grover S.
        • Jaffray D.
        • Rodin D.
        • Torode J.
        • et al.
        Global impact of radiotherapy in oncology: Saving one million lives by 2035.
        Radiother Oncol. 2017; 125: 175-177
        • Zubizarreta E.
        • Van Dyk J.
        • Lievens Y.
        Analysis of global radiotherapy needs and costs by geographic region and income level.
        Clin Oncol. 2017; 29: 84-92
      8. IAEA. Rays of Hope: Cancer care for all 2020.

        • Benstead K.
        • Lara P.C.
        • Eller Y.
        • Engell-Noerregaard L.
        • Eriksen J.G.
        • Gaye P.M.
        • et al.
        Clinical oncology module for the ESTRO core curriculum.
        Radiother Oncol. 2021; 156: 19-22
        • Srivastava A.
        • Jalink M.
        • de Moraes F.Y.
        • Booth C.M.
        • Berry S.R.
        • Rubagumya F.
        • et al.
        Tracking the Workforce 2020–2030: Making the Case for a Cancer Workforce Registry.
        J Glob Oncol. 2021; 7: 925-933
        • Hanna T.
        • Shafiq J.
        • Delaney G.
        • Vinod S.
        • Thompson S.
        • Barton M.
        The population benefit of evidence-based radiotherapy: 5-year local control and overall survival benefits.
        Radiother Oncol. 2018; 126: 191-197
        • Rodin D.
        • Tawk B.
        • Mohamad O.
        • Grover S.
        • Moraes F.Y.
        • Yap M.L.
        • et al.
        Hypofractionated radiotherapy in the real-world setting: an international ESTRO-GIRO survey.
        Radiother Oncol. 2021; 157: 32-39
        • Wilson B.E.
        • Elliott M.J.
        • Pearson S.A.
        • Amir E.
        • Barton M.B.
        Resource stratified guidelines for cancer: Are they all the same? Interguideline concordance for systemic treatment recommendations.
        Int J Cancer. 2022; 150: 91-99
        • Haruyama R.
        • Okawa S.
        • Akaba H.
        • Obara H.
        • Fujita N.
        A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region.
        Vaccines. 2021; 9: 1355